摘要
摘 要:577 nm阈下微脉冲激光(SML)是治疗视网膜疾病的一种非破坏性热激光疗法,具有损伤小、安全性高、穿透能力强等优点,在治疗视网膜疾病等方面具有极大的应用前景。本文综述了577 nm SML在治疗中心性浆液性脉络膜视网膜病变(CSC)、糖尿病性黄斑水肿(DME)、年龄相关性黄斑变性(ARMD)、视网膜静脉阻塞继发黄斑水肿等视网膜疾病中的研究进展,以期能为临床应用提供参考。
关键词:视网膜光凝术;阈下微脉冲激光;视网膜疾病;黄斑
中图分类号:R774 文献标志码:A DOI:10.3969/j.issn.1007-7146.2025.03.002
Abstract
Abstract: 577 nm subthreshold micropulse laser (SML) is a non-destructive thermal laser therapy for the treatment of retinal diseases, which has the advantages of minimal damage, high safety, and strong penetration ability. It showed great development prospects in the treatment of retinal diseases and other fields. This article reviews the research progress of 577 nm SML in the treatment of central serous chorioretinopathy (CSC), diabetic macular edema (DME), age-related macular degeneration (ARMD), macular edema secondary to retinal vein occlusion and other retinal diseases, hoping that it can provide some reference for clinical application.
Key words: retinitis photocoagulation; subthreshold micropulse laser; retinal diseases; macula
(Acta Laser Biology Sinica, 2025, 34(3): 207-213)
朱浩洋,黎维佳,冯 劲,周 丹.
577 nm阈下微脉冲激光治疗视网膜疾病研究进展[J]. 激光生物学报. 2025, 34(3): 207-213
ZHU Haoyang, LI Weijia, FENG Jin, ZHOU Dan.
Research Progress of 577 nm Subthreshold Micropulse Laser in the Treatment of Retinal Diseases#br#[J]. Acta Laser Biology Sinica. 2025, 34(3): 207-213
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}